Pregled bibliografske jedinice broj: 1208091
Sustavna terapija vitaminom D u bolesnika s bolestima kože
Sustavna terapija vitaminom D u bolesnika s bolestima kože // 7. kongres hrvatskih dermatovenerologa s međunarodnim sudjelovanjem
Vodice, Hrvatska, 2022. str. 17-17 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1208091 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Sustavna terapija vitaminom D u bolesnika s
bolestima kože
(Systemic Vitamin D Therapy in Patients with Skin
Diseases)
Autori
Štrbac, Tea ; Rešetar, Josip ; Stanimirović, Andrija
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
7. kongres hrvatskih dermatovenerologa s međunarodnim sudjelovanjem
/ - , 2022, 17-17
Skup
7. kongres hrvatskih dermatovenerologa s međunarodnim sudjelovanjem
Mjesto i datum
Vodice, Hrvatska, 05.08.2022. - 08.08.2022
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
vitamin D ; bolesti kože ; sistemska terapija
(vitamin D ; skin diseases ; systemic therapy)
Sažetak
Background: During the last few years, investigations of the role of vitamin D in certain skin conditions have significantly increased. Numerous laboratory studies have demonstrated the dose-dependent molecular effects of vitamin D and its analogs on cell proliferation, differentiation, and apoptosis. Vitamin D administration was also associated with immunomodulatory, antioxidative, and cytoprotective effects. These findings led to the extended introduction of vitamin D and its analogs in many skin diseases. Objective: Although vitamin D has been used successfully for many years as a topical treatment in many skin conditions, we provide an overview of the pivotal information about the effect of systemic therapy with vitamin D in patients with skin diseases. Methods: The electronic research of the literature included three databases: MEDLINE, Cochrane, and Google Scholar, along with other available literature data. Results: Decreased vitamin D level in serum was found in patients with psoriasis, vitiligo, scleroderma, alopecia areata, and congenital ichthyosis. A clinical amelioration, after systemic administration of vitamin D, was observed in patients with psoriasis, vitiligo, and congenital ichthyosis. Currently, there is insufficient evidence of treatment outcome in patients with scleroderma and alopecia areata. Vitamin D may reduce clinical features in atopic dermatitis, but data about the long-term effects are still missing. Vitamin D deficiency is correlated with the severity of acne vulgaris, as well as hidradenitis suppurativa – in these conditions, some studies support the use of peroral D3 vitamin as a therapy. Contrary, in lupus erythematosus, administration of vitamin D is shown to be ineffective in cutaneous manifestations of the disease. Finally, oral administration of vitamin D may improve the clinical presentation of skin tumors, but does not affect the survival rate. Conclusion: The effects of systemic vitamin D analogs in the clinical treatment of many skin diseases are promising, but further clinical studies are needed.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Farmacija, Nutricionizam
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Zdravstveno veleučilište, Zagreb,
Opća bolnica Zabok